SARS-CoV2 RECEPTOR TARGETING FOR THE TREATMENT OF COVID 19 PATIENTS (CORONAVIRUS RECEPTOR TARGETING -“CORTAR”) Urtea: 2020 Finantzaketa egin duen erakundea: EUSKAMPUS. 2021
